Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr has removed all 17 members of the CDC's Advisory Committee on ...

Currently available PCSK9-targeting therapies are Amgen's Repatha (evolocumab) and Sanofi/Regeneron's Praluent (alirocumab), ...

Asked where AI is having the biggest impact in digital engagement, around half (49%) of respondents said it was in data ...

The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...

NewAmsterdam Pharma has said that an oral drug it is developing to lower cholesterol has shown preliminary efficacy as a ...

AbbVie presented new data from its novel antibody-drug conjugates (ADCs) at ASCO 2025, including telisotuzumab adizutecan ...